Insulin Degludec: Pharmacokinetics in Patients with Renal Impairment

BACKGROUND: Insulin degludec is a new-generation basal insulin with an ultra-long duration of action. We evaluated the pharmacokinetic properties of insulin degludec in subjects with normal renal function; mild, moderate or severe renal impairment; or end-stage renal disease (ESRD) undergoing hemodi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kiss, István, Arold, Gerhard, Roepstorff, Carsten, Bøttcher, Susanne Gammelgaard, Klim, Søren, Haahr, Hanne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2013
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3899495/
https://www.ncbi.nlm.nih.gov/pubmed/24163264
http://dx.doi.org/10.1007/s40262-013-0113-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3899495/
https://www.ncbi.nlm.nih.gov/pubmed/24163264
http://dx.doi.org/10.1007/s40262-013-0113-2

Ejemplares similares